发明名称 Substituted benzoylguanidines, process for their preparation, their use as a pharmaceutical as inhibitors of the cellular NA+/H+ exchange or as a diagnostic, and pharmaceutical containing them
摘要 Substituted benzoylguanidines, process for their preparation, their use as a pharmaceutical or diagnostic, and pharmaceutical containing them. Described are benzoylguanidines of the formula I <IMAGE> (I) where R(1) to R(3) are H, Hal, (cyclo)alkyl, N3, CN or OH, alkyloxy, phenyl, phenoxy or benzoyl, and their pharmacologically acceptable salts, but with the exception of the compounds benzoylguanidine, 4-chlorobenzoylguanidine, 3,4-dichlorobenzoylguanidine and 3- or 4-methylbenzoylguanidine. They are obtained by reacting a compound II <IMAGE> (II) with guanidine, L being a leaving group.
申请公布号 US5866610(A) 申请公布日期 1999.02.02
申请号 US19960683141 申请日期 1996.07.18
申请人 HOECHST AKTIENGESELLSCHAFT 发明人 LANG, HANS-JOCHEN;WEICHERT, ANDREAS;KLEEMANN, HEINZ-WERNER;SCHWARK, JAN-ROBERT;SCHOLZ, WOLFGANG;ALBUS, UDO
分类号 A61K31/165;A61K31/155;A61K31/166;A61K31/44;A61K31/47;A61K31/472;A61P1/04;A61P1/16;A61P3/10;A61P7/02;A61P9/00;A61P9/02;A61P9/06;A61P9/08;A61P9/10;A61P9/12;A61P11/00;A61P13/08;A61P13/12;A61P35/00;A61P43/00;C07C233/65;C07C277/08;C07C279/18;C07C279/22;C07D213/30;C07D213/56;C07D215/14;C07D215/50;C07D217/18;C07D217/24;(IPC1-7):A61K31/165 主分类号 A61K31/165
代理机构 代理人
主权项
地址